An observational study of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab

Affiliations

• ¹ Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
• ² Department of Dermatology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.
• ³ Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China; Allergy Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
• ⁴ Central Laboratory, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China. Electronic address: gongtingfy@fjmu.edu.cn.
• ⁵ Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China; Key Laboratory of Skin Cancer of Fujian Higher Education Institutions, Fuzhou, Fujian, China. Electronic address: jichaofy@fjmu.edu.cn.